Standard BioTools Inc.

Historical 13F Holders

Symbol
LAB
CUSIP
34385P108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 34385P108 since 12/18/2024, largest first.

Filer % of Class Filed
Casdin Capital, LLC 13D/A
23.9% 6/9/2026
Event 6/6/2026
Viking Global Investors LP 13D
15.0% 6/12/2026
Event 6/6/2026
Mak Capital One LLC 13G/A
7.3% 8/14/2026
Event 6/30/2026
MAK Capital Fund LP 13G/A
6.7% 5/15/2026
Event 3/31/2026
Long Focus Capital Management, LLC 13G
6.0% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
BlackRock, Inc. 13G/A 2.0% 7/30/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 20 8.88 M $6.57 M
2026 Q2 143 296 M $244 M
2026 Q1 156 297 M $273 M
2025 Q4 159 303 M $387 M
2025 Q3 156 291 M $378 M
2025 Q2 161 281 M $337 M
2025 Q1 147 285 M $308 M
2024 Q4 143 278 M $487 M
2024 Q3 142 281 M $543 M
2024 Q2 148 284 M $503 M
2024 Q1 148 281 M $762 M
2023 Q4 87 52.8 M $117 M
2023 Q3 73 47.4 M $138 M
2023 Q2 67 46.2 M $89.1 M
2023 Q1 70 46.1 M $89.9 M
2022 Q4 70 46.8 M $54.7 M
2022 Q3 68 38.6 M $42.5 M
2022 Q2 89 43.9 M $70.2 M
2022 Q1 112 50.0 M $180 M
2021 Q4 125 56.5 M $221 M
2021 Q3 122 58.6 M $387 M
2021 Q2 116 57.6 M $354 M
2021 Q1 140 59.4 M $269 M
2020 Q4 147 66.4 M $398 M
2020 Q3 137 66.9 M $501 M
2020 Q2 115 62.8 M $252 M
2020 Q1 104 64.1 M $163 M
2019 Q4 100 65.0 M $226 M
2019 Q3 126 63.9 M $296 M
2019 Q2 136 70.8 M $872 M
2019 Q1 133 64.7 M $860 M
2018 Q4 100 49.9 M $430 M
2018 Q3 81 39.3 M $294 M
2018 Q2 85 38.2 M $227 M
2018 Q1 87 37.1 M $217 M
2017 Q4 82 36.7 M $217 M
2017 Q3 82 36.2 M $182 M
2017 Q2 82 26.3 M $106 M
2017 Q1 82 27.2 M $155 M
2016 Q4 85 27.0 M $196 M
2016 Q3 99 27.2 M $218 M
2016 Q2 101 27.3 M $246 M
2016 Q1 104 28.5 M $230 M
2015 Q4 110 28.5 M $308 M
2015 Q3 111 31.1 M $252 M
2015 Q2 109 31.0 M $750 M
2015 Q1 105 30.6 M $1.29 B
2014 Q4 100 30.5 M $1.03 B
2014 Q3 99 28.7 M $702 M
2014 Q2 105 27.6 M $811 M
2014 Q1 108 26.2 M $1.15 B